ReviewDrug design, development and therapy2026

Progress in the Treatment of Ulcerative Colitis by Targeting NLRP3 Inflammasome.

Jiaying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.